Bong Seok Kang

1.3k total citations
19 papers, 1.1k citations indexed

About

Bong Seok Kang is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Bong Seok Kang has authored 19 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 5 papers in Oncology and 5 papers in Immunology. Recurrent topics in Bong Seok Kang's work include Signaling Pathways in Disease (7 papers), Genomics and Chromatin Dynamics (3 papers) and Melanoma and MAPK Pathways (3 papers). Bong Seok Kang is often cited by papers focused on Signaling Pathways in Disease (7 papers), Genomics and Chromatin Dynamics (3 papers) and Melanoma and MAPK Pathways (3 papers). Bong Seok Kang collaborates with scholars based in United States, South Korea and Russia. Bong Seok Kang's co-authors include Zigang Dong, Ann M. Bode, Bu Young Choi, Hong Seok Choi, Svetlana P. Ermakova, Weiya Ma, Yong‐Yeon Cho, Feng Zhu, Todd Schuster and Hong Seok Choi and has published in prestigious journals such as Journal of Biological Chemistry, Gastroenterology and Cancer Research.

In The Last Decade

Bong Seok Kang

19 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bong Seok Kang United States 14 741 235 215 192 110 19 1.1k
Yancun Yin China 18 654 0.9× 132 0.6× 198 0.9× 186 1.0× 92 0.8× 33 1.2k
Julie Jodoin Canada 16 685 0.9× 164 0.7× 581 2.7× 241 1.3× 56 0.5× 19 1.6k
Jung Ho Back United States 10 619 0.8× 140 0.6× 168 0.8× 52 0.3× 104 0.9× 10 1.2k
Seyung Chung United States 18 844 1.1× 106 0.5× 410 1.9× 108 0.6× 90 0.8× 23 1.3k
Chang-Mo Kang South Korea 13 887 1.2× 77 0.3× 242 1.1× 178 0.9× 92 0.8× 18 1.3k
Hiroyuki Sadano Japan 17 439 0.6× 115 0.5× 153 0.7× 159 0.8× 47 0.4× 27 782
Antonella Cusimano Italy 22 738 1.0× 156 0.7× 232 1.1× 95 0.5× 97 0.9× 35 1.2k
Yuan‐Chiang Chung Taiwan 18 310 0.4× 57 0.2× 212 1.0× 82 0.4× 62 0.6× 35 778
Danielly C. Ferraz da Costa Brazil 15 761 1.0× 104 0.4× 384 1.8× 89 0.5× 39 0.4× 31 1.1k
Qingdi Quentin Li China 18 393 0.5× 111 0.5× 183 0.9× 45 0.2× 59 0.5× 28 841

Countries citing papers authored by Bong Seok Kang

Since Specialization
Citations

This map shows the geographic impact of Bong Seok Kang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bong Seok Kang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bong Seok Kang more than expected).

Fields of papers citing papers by Bong Seok Kang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bong Seok Kang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bong Seok Kang. The network helps show where Bong Seok Kang may publish in the future.

Co-authorship network of co-authors of Bong Seok Kang

This figure shows the co-authorship network connecting the top 25 collaborators of Bong Seok Kang. A scholar is included among the top collaborators of Bong Seok Kang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bong Seok Kang. Bong Seok Kang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
2.
Kang, Bong Seok, Yoon Jin Hwang, & Zigang Dong. (2017). ERK1 Directly Interacts With JNK1 Leading to Regulation of JNK1/c-Jun Activity and Cell Transformation. Journal of Cellular Biochemistry. 118(8). 2357–2370. 4 indexed citations
3.
Jo, Ara, Hyo Jeong Yun, Jin Young Kim, et al.. (2015). Prolyl isomerase PIN1 negatively regulates SGK1 stability to mediate tamoxifen resistance in breast cancer cells.. PubMed. 35(2). 785–94. 10 indexed citations
4.
Nam, Jeong‐Seok, et al.. (2012). Apoptotic effect of dibenzylideneacetone on oral cancer cells via modulation of specificity protein 1 and Bax. Oral Diseases. 19(8). 767–774. 24 indexed citations
5.
Khanal, Prem, et al.. (2011). Aglycon of Rhizochalin from the Rhizochalina incrustata Induces Apoptosis via Activation of AMP-Activated Protein Kinase in HT-29 Colon Cancer Cells. Biological and Pharmaceutical Bulletin. 34(10). 1553–1558. 21 indexed citations
7.
Khanal, Prem, et al.. (2010). The Prolyl Isomerase Pin1 Induces LC-3 Expression and Mediates Tamoxifen Resistance in Breast Cancer. Journal of Biological Chemistry. 285(31). 23829–23841. 47 indexed citations
8.
Cho, Yong‐Yeon, Ke Yao, Hong-Gyum Kim, et al.. (2007). Ribosomal S6 Kinase 2 Is a Key Regulator in Tumor Promoter–Induced Cell Transformation. Cancer Research. 67(17). 8104–8112. 95 indexed citations
9.
Cho, Yong‐Yeon, Ke Yao, Ann M. Bode, et al.. (2007). RSK2 Mediates Muscle Cell Differentiation through Regulation of NFAT3. Journal of Biological Chemistry. 282(11). 8380–8392. 65 indexed citations
10.
Zhu, Feng, Tatyana A. Zykova, Bong Seok Kang, et al.. (2007). Bidirectional Signals Transduced by TOPK-ERK Interaction Increase Tumorigenesis of HCT116 Colorectal Cancer Cells. Gastroenterology. 133(1). 219–231. 126 indexed citations
11.
Choi, Hong Seok, Bong Seok Kang, Jung‐Hyun Shim, et al.. (2007). Cot, a novel kinase of histone H3, induces cellular transformation through up‐regulation of c‐fos transcriptional activity. The FASEB Journal. 22(1). 113–126. 25 indexed citations
12.
Oh, Sang‐Muk, Feng Zhu, Yong‐Yeon Cho, et al.. (2007). T-Lymphokine–Activated Killer Cell–Originated Protein Kinase Functions as a Positive Regulator of c-Jun-NH2-Kinase 1 Signaling and H-Ras–Induced Cell Transformation. Cancer Research. 67(11). 5186–5194. 55 indexed citations
13.
Ermakova, Svetlana P., Bong Seok Kang, Bu Young Choi, et al.. (2006). (−)−Epigallocatechin Gallate Overcomes Resistance to Etoposide-Induced Cell Death by Targeting the Molecular Chaperone Glucose-Regulated Protein 78. Cancer Research. 66(18). 9260–9269. 232 indexed citations
14.
Cho, Yong‐Yeon, Zhiwei He, Yiguo Zhang, et al.. (2005). The p53 Protein Is a Novel Substrate of Ribosomal S6 Kinase 2 and a Critical Intermediary for Ribosomal S6 Kinase 2 and Histone H3 Interaction. Cancer Research. 65(9). 3596–3603. 62 indexed citations
15.
Choi, Bu Young, Hong Seok Choi, Yong‐Yeon Cho, et al.. (2005). The tumor suppressor p16INK4a prevents cell transformation through inhibition of c-Jun phosphorylation and AP-1 activity. Nature Structural & Molecular Biology. 12(8). 699–707. 68 indexed citations
16.
Ermakova, Svetlana P., Bu Young Choi, Hong Seok Choi, et al.. (2005). The Intermediate Filament Protein Vimentin Is a New Target for Epigallocatechin Gallate. Journal of Biological Chemistry. 280(17). 16882–16890. 128 indexed citations
17.
Choi, Hong Seok, Bu Young Choi, Yong‐Yeon Cho, et al.. (2005). Phosphorylation of Histone H3 at Serine 10 Is Indispensable for Neoplastic Cell Transformation. Cancer Research. 65(13). 5818–5827. 90 indexed citations
18.
Kang, Bong Seok, Yeon‐Jeong Kim, Eun Young Song, et al.. (1998). Identification of a New 5'-Noncoding Exon Region and Promoter Activity in Human N-Acetylglucosaminyltransferase III Gene. BMB Reports. 31(6). 578–584. 4 indexed citations
19.
Kang, Bong Seok, Jeong Heon Ko, Jin Suk Park, et al.. (1996). Genomic heterogeneity in clinical strains of Mycobacterium tuberculosis, M. terrae complex, M. gordonae, M. avium-intracellulae complex and M. fortuitum by pulsed-field gel electrophoresis. BMB Reports. 29(6). 569–573. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026